Enfusion Inc (ENFN)

$8.73

-0.03

(-0.34%)▲

Live

Performance

  • $8.68
    $8.79
    $8.73
    downward going graph

    0.52%

    Downside

    Day's Volatility :1.2%

    Upside

    0.68%

    downward going graph
  • $7.52
    $10.45
    $8.73
    downward going graph

    13.86%

    Downside

    52 Weeks Volatility :28.04%

    Upside

    16.46%

    downward going graph

Returns

PeriodEnfusion IncSector (Technology)Index (Russel 2000)
3 Months
-4.78%
4.5%
0.0%
6 Months
-5.09%
19.9%
0.0%
1 Year
0.0%
40.9%
0.0%
3 Years
-55.78%
45.3%
-23.0%

Highlights

Market Capitalization
821.2M
Book Value
$0.70
Earnings Per Share (EPS)
0.04
PE Ratio
220.25
Wall Street Target Price
9.31
Profit Margin
1.99%
Operating Margin TTM
5.47%
Return On Assets TTM
3.74%
Return On Equity TTM
6.61%
Revenue TTM
188.4M
Revenue Per Share TTM
2.11
Quarterly Revenue Growth YOY
15.8%
Gross Profit TTM
103.2M
EBITDA
13.8M
Diluted Eps TTM
0.04
Quarterly Earnings Growth YOY
1.57
EPS Estimate Current Year
0.22
EPS Estimate Next Year
0.3
EPS Estimate Current Quarter
0.06
EPS Estimate Next Quarter
0.06

Analyst Recommendation

Sell
    23%Buy
    30%Hold
    46%Sell
Based on 13 Wall street analysts offering stock ratings for Enfusion Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
3
3
8
Hold
4
4
4
Sell
6
6
2

Analyst Forecast

What analysts predicted

Upside of 6.64%

Current $8.73
Target $9.31

Company Financials

FY19Y/Y Change
Revenue
59.0M
-
Net Income
12.7M
-
Net Profit Margin
21.44%
-
FY20Y/Y Change
Revenue
79.6M
↑ 34.79%
Net Income
4.1M
↓ 67.91%
Net Profit Margin
5.1%
↓ 16.34%
FY21Y/Y Change
Revenue
111.7M
↑ 40.39%
Net Income
-282.2M
↓ 7050.06%
Net Profit Margin
-252.68%
↓ 257.78%
FY22Y/Y Change
Revenue
150.3M
↑ 34.6%
Net Income
-13.3M
↓ 95.3%
Net Profit Margin
-8.82%
↑ 243.86%
FY23Y/Y Change
Revenue
174.5M
↑ 16.09%
Net Income
6.0M
↓ 145.43%
Net Profit Margin
3.45%
↑ 12.27%
Q1 FY23Q/Q Change
Revenue
41.0M
↑ 1.12%
Net Income
4.7M
↑ 495.69%
Net Profit Margin
11.46%
↑ 9.52%
Q2 FY23Q/Q Change
Revenue
42.7M
↑ 4.27%
Net Income
629.0K
↓ 86.6%
Net Profit Margin
1.47%
↓ 9.99%
Q3 FY23Q/Q Change
Revenue
44.4M
↑ 3.83%
Net Income
1.8M
↑ 190.62%
Net Profit Margin
4.12%
↑ 2.65%
Q4 FY23Q/Q Change
Revenue
46.5M
↑ 4.8%
Net Income
623.0K
↓ 65.92%
Net Profit Margin
1.34%
↓ 2.78%
Q1 FY24Q/Q Change
Revenue
48.1M
↑ 3.37%
Net Income
-539.0K
↓ 186.52%
Net Profit Margin
-1.12%
↓ 2.46%
Q2 FY24Q/Q Change
Revenue
49.5M
↑ 2.92%
Net Income
1.8M
↓ 438.78%
Net Profit Margin
3.69%
↑ 4.81%
FY19Y/Y Change
Total Assets
23.2M
-
Total Liabilities
141.1M
-
FY20Y/Y Change
Total Assets
39.1M
↑ 68.55%
Total Liabilities
272.7M
↑ 93.27%
FY21Y/Y Change
Total Assets
106.1M
↑ 171.32%
Total Liabilities
8.6M
↓ 96.83%
FY22Y/Y Change
Total Assets
123.8M
↑ 16.68%
Total Liabilities
20.3M
↑ 135.3%
FY23Y/Y Change
Total Assets
109.0M
↓ 11.97%
Total Liabilities
31.5M
↑ 54.83%
Q1 FY23Q/Q Change
Total Assets
121.5M
↓ 1.85%
Total Liabilities
22.3M
↑ 9.88%
Q2 FY23Q/Q Change
Total Assets
94.1M
↓ 22.59%
Total Liabilities
21.8M
↓ 2.41%
Q3 FY23Q/Q Change
Total Assets
101.7M
↑ 8.17%
Total Liabilities
28.5M
↑ 30.5%
Q4 FY23Q/Q Change
Total Assets
109.0M
↑ 7.11%
Total Liabilities
31.5M
↑ 10.63%
Q1 FY24Q/Q Change
Total Assets
111.0M
↑ 1.83%
Total Liabilities
28.3M
↓ 10.01%
Q2 FY24Q/Q Change
Total Assets
120.1M
↑ 8.23%
Total Liabilities
30.7M
↑ 8.25%
FY19Y/Y Change
Operating Cash Flow
12.3M
-
Investing Cash Flow
-4.4M
-
Financing Cash Flow
-7.5M
-
FY20Y/Y Change
Operating Cash Flow
1.7M
↓ 86.47%
Investing Cash Flow
-5.1M
↑ 14.43%
Financing Cash Flow
11.6M
↓ 253.28%
FY21Y/Y Change
Operating Cash Flow
-318.0K
↓ 119.1%
Investing Cash Flow
-8.0M
↑ 58.13%
Financing Cash Flow
58.8M
↑ 409.12%
FY22Y/Y Change
Operating Cash Flow
14.2M
↓ 4551.57%
Investing Cash Flow
-7.9M
↓ 1.04%
Financing Cash Flow
-8.0M
↓ 113.52%
Q1 FY23Q/Q Change
Operating Cash Flow
924.0K
↓ 87.71%
Investing Cash Flow
-2.6M
↑ 46.05%
Financing Cash Flow
-6.4M
↓ 9.78%
Q2 FY23Q/Q Change
Operating Cash Flow
6.0M
↑ 551.3%
Investing Cash Flow
-2.2M
↓ 12.98%
Financing Cash Flow
-30.8M
↑ 385.47%
Q3 FY23Q/Q Change
Operating Cash Flow
12.1M
↑ 101.16%
Investing Cash Flow
-2.6M
↑ 17.49%
Financing Cash Flow
-5.3M
↓ 82.79%

Technicals Summary

Sell

Neutral

Buy

Enfusion Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enfusion Inc
Enfusion Inc
-7.79%
-5.09%
0.0%
-55.78%
-55.78%
Uber Technologies, Inc.
Uber Technologies, Inc.
5.96%
14.76%
83.92%
70.35%
152.02%
Servicenow, Inc.
Servicenow, Inc.
-0.41%
27.68%
70.26%
34.3%
282.63%
Salesforce Inc
Salesforce Inc
10.87%
6.99%
45.02%
1.08%
102.66%
Intuit Inc.
Intuit Inc.
-4.47%
0.58%
21.68%
6.04%
133.9%
Automatic Data Processing, Inc.
Automatic Data Processing, Inc.
5.3%
18.67%
21.2%
36.13%
80.39%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enfusion Inc
Enfusion Inc
220.25
220.25
NA
0.22
0.07
0.04
NA
0.7
Uber Technologies, Inc.
Uber Technologies, Inc.
86.85
86.85
1.24
1.05
0.19
0.03
NA
5.89
Servicenow, Inc.
Servicenow, Inc.
166.45
166.45
2.52
13.78
0.15
0.04
NA
42.1
Salesforce Inc
Salesforce Inc
50.8
50.8
1.57
8.2
0.1
0.05
0.01
60.16
Intuit Inc.
Intuit Inc.
58.86
58.86
1.86
16.83
0.17
0.08
0.01
65.78
Automatic Data Processing, Inc.
Automatic Data Processing, Inc.
32.08
32.08
3.86
9.15
0.93
0.06
0.02
11.14
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enfusion Inc
Enfusion Inc
Sell
$821.2M
-55.78%
220.25
1.99%
Uber Technologies, Inc.
Uber Technologies, Inc.
Buy
$167.9B
152.02%
86.85
5.02%
Servicenow, Inc.
Servicenow, Inc.
Buy
$188.8B
282.63%
166.45
11.51%
Salesforce Inc
Salesforce Inc
Buy
$278.3B
102.66%
50.8
15.45%
Intuit Inc.
Intuit Inc.
Buy
$171.9B
133.9%
58.86
18.2%
Automatic Data Processing, Inc.
Automatic Data Processing, Inc.
Hold
$119.1B
80.39%
32.08
19.54%

Insights on Enfusion Inc

  • Increasing Revenue

    Revenue is up for the last 16 quarters, 19.78M → 49.45M (in $), with an average increase of 5.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -539.0K → 1.82M (in $), with an average increase of 129.5% per quarter

  • Vs UBER

    In the last 1 year, Uber Technologies, Inc. has given 84.3% return, outperforming this stock by 84.3%

Institutional Holdings

  • ICONIQ Capital, LLC

    15.06%

  • Brown Capital Management, LLC

    9.20%

  • Hillhouse Capital Advisors, Ltd.

    5.34%

  • Vanguard Group Inc

    4.07%

  • Ararat Capital Management, LP

    3.60%

  • BlackRock Inc

    3.30%

Company Information

enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.

Organization
Enfusion Inc
Employees
1102
CEO
Mr. Oleg Movchan
Industry
Technology

Discover More

FAQs